SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
+11.74%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$130M
AUM Growth
+$130M
(+35%)
Cap. Flow
+$21.8M
Cap. Flow
% of AUM
16.75%
Top 10 Holdings %
Top 10 Hldgs %
63.42%
Holding
63
New
18
Increased
8
Reduced
9
Closed
10
Top Buys
| 1 |
Sanofi
SNY
|
$12.2M |
| 2 |
Biogen
BIIB
|
$7.56M |
| 3 |
Puma Biotechnology
PBYI
|
$5.95M |
| 4 |
Thermo Fisher Scientific
TMO
|
$4.61M |
| 5 |
GSK
GSK
|
$3.4M |
Top Sells
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$5.98M |
| 2 |
Edwards Lifesciences
EW
|
$5.15M |
| 3 |
Zimmer Biomet
ZBH
|
$4.82M |
| 4 |
Aclaris Therapeutics
ACRS
|
$3.76M |
| 5 |
NTUS
Natus Medical Inc
NTUS
|
$3.16M |
Sector Composition
| 1 | Healthcare | 88.21% |
| 2 | Industrials | 4.3% |
| 3 | Financials | 3.64% |
| 4 | Technology | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $16.3M | 9.14% | 2,338,061 +100,290 | +4% | +$701K |
|
|
2
Sanofi
SNY
$121B
| $12.2M | 6.84% | +270,422 | New | +$12.2M |
|
|
3
GSK
GSK
$79.9B
| $11M | 6.17% | 261,513 +80,702 | +45% | +$3.4M |
|
4
Philips
PHG
$26.2B
| $7.84M | 4.39% | 244,186 +34,684 | +17% | +$1.11M |
|
|
5
Biogen
BIIB
$19.4B
| $7.56M | 4.23% | +27,650 | New | +$7.56M |
|
6
Rigel Pharmaceuticals
RIGL
$697M
| $6.25M | 3.5% | 1,888,181 +624,791 | +49% | +$2.07M |
|
|
7
Puma Biotechnology
PBYI
$254M
| $5.95M | 3.33% | +160,064 | New | +$5.95M |
|
|
TRHC
8
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $5.58M | 3.12% | 414,045 +25,991 | +7% | +$350K |
|
9
Eli Lilly
LLY
$657B
| $4.86M | 2.72% | 57,786 -9,214 | -14% | -$775K |
|
|
AET
10
DELISTED
Aetna Inc
AET
| $4.73M | 2.65% | 37,100 +17,100 | +86% | +$2.18M |
|
11
Cardinal Health
CAH
$35.5B
| $4.73M | 2.64% | 57,950 -10,935 | -16% | -$892K |
|
|
12
Thermo Fisher Scientific
TMO
$186B
| $4.61M | 2.58% | +30,000 | New | +$4.61M |
|
|
AAAP
13
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $4.33M | 2.42% | 108,523 -44,809 | -29% | -$1.79M |
|
|
DMK
14
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $3.75M | 2.1% | 882,862 -168,201 | -16% | -$715K |
|
15
UnitedHealth
UNH
$281B
| $3.47M | 1.94% | 21,151 +4,964 | +31% | +$814K |
|
16
Medtronic
MDT
$119B
| $2.42M | 1.35% | +30,000 | New | +$2.42M |
|
17
Smith & Nephew
SNN
$16.3B
| $2.39M | 1.34% | +77,244 | New | +$2.39M |
|
18
Boston Scientific
BSX
$156B
| $2.24M | 1.25% | 90,000 -23,500 | -21% | -$584K |
|
19
Teva Pharmaceuticals
TEVA
$21.1B
| $2.23M | 1.25% | +69,500 | New | +$2.23M |
|
|
CCXI
20
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.14M | 1.2% | 294,150 -31,100 | -10% | -$226K |
|
21
Vertex Pharmaceuticals
VRTX
$100B
| $2.13M | 1.19% | +19,475 | New | +$2.13M |
|
22
Globus Medical
GMED
$8.27B
| $1.78M | 0.99% | +60,000 | New | +$1.78M |
|
23
Rocket Pharmaceuticals
RCKT
$354M
| $1.45M | 0.81% | +726,900 | New | +$1.45M |
|
24
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $1.35M | 0.75% | +63,800 | New | +$1.35M |
|
|
VIRX
25
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $1.28M | 0.72% | +311,925 | New | +$1.28M |
|